1. Aryl[ a ]pyrrolo[3,4- c ]carbazoles as selective cyclin D1-CDK4 inhibitors
- Author
-
Margaret M. Faul, Christine A. Kumrich, Bryan A. Anderson, Concha Sanchez-Martinez, Tammy B. DeHahn, Harold B. Brooks, Catherine A. Ogg, Michael Paal, Robert M. Campbell, Carmen Somoza, Tiechao Li, Leonard L. Winneroski, Bharvin K. R. Patel, Chuan Shih, Zhou Xun, Jill R. Wagner, Eileen L. Considine, Guoxin Zhu, Scott A. Watkins, Jack A. Dempsey, Richard M. Schultz, and Charles D. Spencer
- Subjects
Stereochemistry ,Clinical Biochemistry ,Carbazoles ,Pharmaceutical Science ,Antineoplastic Agents ,Ring (chemistry) ,Biochemistry ,Chemical synthesis ,chemistry.chemical_compound ,Polycyclic compound ,Cyclin D1 ,Cell Line, Tumor ,Proto-Oncogene Proteins ,Drug Discovery ,Humans ,Pyrroles ,Imide ,Molecular Biology ,Indole test ,chemistry.chemical_classification ,integumentary system ,biology ,Aryl ,Organic Chemistry ,Cyclin-Dependent Kinase 4 ,Cyclin-Dependent Kinases ,chemistry ,Enzyme inhibitor ,biology.protein ,Molecular Medicine ,Cell Division - Abstract
The synthesis of new analogues of Arcyriaflavin A in which one indole ring is replaced by an aryl or heteroaryl ring is described. These new series of aryl[a]pyrrolo[3,4-c]carbazoles were evaluated as inhibitors of Cyclin D1-CDK4. A potent and selective D1-CDK4 inhibitor, 7a (D1-CDK4 IC(50)=45 nM), has been identified. The potency, selectivity profile against other kinases, and structure-activity relationship (SAR) trends of this class of compounds are discussed.
- Published
- 2003
- Full Text
- View/download PDF